Clinical trial Recruiting at 1 site Observational Ages 55 to 80

A study on brain health and aging in Bordeaux.

Official title: Biobank and Brain Health in Bordeaux. A Population-based Cohort to Study the Biology of Brain and Cognitive Aging in Young Seniors

Run by University Hospital, Bordeaux · NCT05322343 · Data updated 2026-11-12

This study is trying to understand how different factors, like diet and health, affect brain aging and the risk of dementia in people aged 55 and older living in Bordeaux.

Quick facts

Study typeObservational
Ages55 Years to 80 Years
SexAll
Enrollment2050 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux, Bordeaux)
StatusRecruiting
StartedMarch 22, 2022
Main results expectedMarch 22, 2030
Study endsMarch 22, 2030
Registry record updatedAugust 11, 2025
Trial IDNCT05322343 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 55 to 80 living in the Bordeaux metropolitan area who are willing to participate in biological sampling.

Probably not a fit

Patients under guardianship or those unable to provide consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the determinants and natural history of brain aging in a representative sample of 2000 individuals aged 55 and older from the Bordeaux metropolitan area. It employs molecular epidemiology methods to explore various factors, including nutrition, that may influence cognitive aging and the onset of dementia. Participants will undergo a series of assessments, including questionnaires and biological sample collections, to gather comprehensive data on their health and environmental exposures. The study seeks to enhance understanding of cognitive aging and inform prevention strategies.

Why it matters

Potential benefit: If successful, this study could lead to improved prevention strategies for cognitive aging and dementia.

How similar studies have gone: Previous population-based cohorts have successfully contributed to understanding aging and dementia, indicating a strong foundation for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For the main study:

1. live in Bordeaux metropolitan area,
2. be between 55 and 80 years old (included),
3. selected in terms of socioeconomic level, according to a sampling strategy by age groups and income categories representative of the general population between 55 and 80 years of age
4. be affiliated with the social security system,
5. agree to take a blood sample for the biobank.

For the MRI sub-study: be between 55 and 75 years old (included). Inclusion criteria for the immune response substudy: be 70 years of age or older or participate in the MRI study; agree to take a supplemental blood sample for this substudy.

Exclusion Criteria:

For the main study: persons under guardianship (or more generally under protection), unable to give consent to participate.

For the MRI sub-study: have a contraindication to MRI examination (pacemaker, a valve prosthesis or any other internal electrical/magnetic device; history of neurosurgery or aneurysm; claustrophobia; presence of metal fragments in the eyes, brain or spinal cord).

Where it's running

  • University Hospital of Bordeaux
    Bordeaux, Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.